After Sinner’s positive test a few months ago, it was the Polish Iga Swiatek who tested positive.
New doping case in the world of tennis with the one-month suspension of Iga Swiatek after a positive test last August for trimetazidine during a period without competition. A thunderbolt announced by the International Tennis Integrity Agency this Thursday, November 28.
The Polish woman mentioned unintentional taking and contaminated medication, because the Polish woman consumed them due to jet lag and sleep problems. After filing an appeal, the four-time Roland-Garros winner finally accepted her sanction, believing that the level of fault was “at the lower end of the range corresponding to the absence of significant fault or negligence”.
The former world No. 1 was provisionally suspended from September 22 to October 4, missing the Asian tour. She now has 8 days left to serve which she will be able to do at the start of the 2025 tennis season.
What is trimetazidine?
It is a medicine used primarily in the treatment of stable angina (angina), a condition related to insufficient oxygen supply to the heart muscle. It acts as an anti-ischemic agent and aims to protect heart cells against damage caused by reduced oxygen supply.